These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7475891)

  • 21. 3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex.
    Lyon RA; Titeler M; Frost JJ; Whitehouse PJ; Wong DF; Wagner HN; Dannals RF; Links JM; Kuhar MJ
    J Neurosci; 1986 Oct; 6(10):2941-9. PubMed ID: 2944994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats.
    Mach RH; Nowak PA; Moroney DA; Morton TE; Jackson JR; Ehrenkaufer RL
    Nucl Med Biol; 1993 Apr; 20(3):269-78. PubMed ID: 8485486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
    Frost JJ; Smith AC; Kuhar MJ; Dannals RF; Wagner HN
    Life Sci; 1987 Mar; 40(10):987-95. PubMed ID: 3821368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D
    Fazio P; Schain M; Mrzljak L; Amini N; Nag S; Al-Tawil N; Fitzer-Attas CJ; Bronzova J; Landwehrmeyer B; Sampaio C; Halldin C; Varrone A
    Neuroimage; 2017 May; 152():330-339. PubMed ID: 28254508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S
    Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
    Nordström AL; Farde L; Nyberg S; Karlsson P; Halldin C; Sedvall G
    Am J Psychiatry; 1995 Oct; 152(10):1444-9. PubMed ID: 7573582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
    Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
    [No Abstract]   [Full Text] [Related]  

  • 30. Labelling of D2-dopaminergic and 5-HT2-serotonergic binding sites in human trophoblastic cells using [3H]-spiperone.
    Vaillancourt C; Petit A; Gallo-Payet N; Bellabarba D; Lehoux JG; Bélisle S
    J Recept Res; 1994 Jan; 14(1):11-22. PubMed ID: 8158579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
    Heinz A; Siessmeier T; Wrase J; Buchholz HG; Gründer G; Kumakura Y; Cumming P; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
    Am J Psychiatry; 2005 Aug; 162(8):1515-20. PubMed ID: 16055774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects.
    Nyberg S; Farde L; Halldin C
    Neuropsychopharmacology; 1997 Jan; 16(1):1-7. PubMed ID: 8981383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin-2 and dopamine-1 binding components of clozapine in frontal cortex and striatum in the human brain visualized by positron emission tomography.
    Lundberg T; Lindström L; Hartvig P; Reibring L; Agren H; Lundqvist H; Fasth KJ; Antoni G; Långström B
    Psychiatry Res; 1996 May; 67(1):1-10. PubMed ID: 8797237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related loss of extrastriatal dopamine D(2) -like receptors in women.
    Kaasinen V; Kemppainen N; Någren K; Helenius H; Kurki T; Rinne JO
    J Neurochem; 2002 Jun; 81(5):1005-10. PubMed ID: 12065612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
    Volkow ND; Fowler JS; Wang GJ; Hitzemann R; Logan J; Schlyer DJ; Dewey SL; Wolf AP
    Synapse; 1993 Jun; 14(2):169-77. PubMed ID: 8101394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
    Messa C; Colombo C; Moresco RM; Gobbo C; Galli L; Lucignani G; Gilardi MC; Rizzo G; Smeraldi E; Zanardi R; Artigas F; Fazio F
    Psychopharmacology (Berl); 2003 Apr; 167(1):72-8. PubMed ID: 12632246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET].
    Iyo M; Yamasaki T; Fukuda H; Inoue O; Suzuki K; Shinotoh H; Ito T; Yonezawa H; Nishio M; Koseki A
    Kaku Igaku; 1989 Feb; 26(2):213-20. PubMed ID: 2525202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
    Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
    Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
    Rinne JO; Hietala J; Ruotsalainen U; Säkö E; Laihinen A; Någren K; Lehikoinen P; Oikonen V; Syvälahti E
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):310-4. PubMed ID: 8436624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.